Autoantibodies to nervous system tissue in human and murine systemic lupus erythematosus

Annals of the New York Academy of Sciences

Volumn 823, Issue , 1997, Pages 289-299

  Moore, Patricia M ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY SPECIFICITY; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALIA; MURINAE;

EID: 0030760115     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb48402.x     Document Type: Conference Paper

References (92)

1. DALMAU, J. & J. B. POSNER. 1996. Neurological paraneoplastic syndromes. Springer Semin. Immunopathol. 18: 85-95.
2. MADAIO, M. P., J. CARLSON, J. CATALDO, A. UCCI, P. MIGLIORINI & O. PANKEWYCZ. 1987. Murine monoclonal anti-DNA antibodies bind directly to glomerular antigens and form immune deposits. J. Immunol. 138: 2883-2889.
3. ROBERTS, J. L., R. J. WYATT, M. M. SCHWARTZ & E. J. LEWIS. 1983. Differential characteristics of immune-bound antibodies in diffuse proliferative and membranous forms of lupus glomerulonephritis. Clin. Immunol. Immunopathol. 29: 223-241.
4. MILLS, J. A. 1994. Systemic Lupus Erythematosus. N. Engl. J. Med. 330: 1871-1879.
5. WINFIELD, J. B. & T. MIMURA. 1992. Pathogenetic significance of anti-lymphocyte autoantibodies in systemic lupus erythematosus. Clin. Immunol. Immunopathol. 63: 13-16.
6. KRAKAUER, J., C. BALMACEDA, J. T. GLUCK, J. B. POSNER, M. R. FETELL & J. DALMAU. 1996. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with adenocarcinoma of unknown origin. Neurology 46: 1486-1487.
7. SILLEVIS-SMITT, P., G. MANLEY, J. W. MOLL, J. DALMAU & J. B. POSNER. 1996. Pitfalls in the diagnosis of autoantibodies associated with paraneoplastic neurologic disease. Neurology 46: 1739-1741.
8. VERSCHUUREN, J., L. CHUANG, M. K. ROSENBLUM, F. LIEBERMAN, A. PRYOR, J. B. POSNER & J. DALMAU. 1996. Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration. Acta Neuropathol. 91: 519-525.
9. DALMAU, J., F. GRAUS, N. K. CHEUNG, M. K. ROSENBLUM, A. HO, A. CANETE, J. Y. DELATTRE, S. J. THOMPSON & J. B. POSNER. 1995. Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer. Cancer 75: 99-109.
10. POSNER, J. B. 1995. Anti-Hu autoantibody associated sensory neuropathy/encephalomyelitis: a model of paraneoplastic syndrome. Perspectives in Biology & Medicine 38: 167-181.
11. LI, L., W. A. HAGOPIAN, H. R. BRASHEAR, T. DANIELS & A. LERNMARK. 1994. Identification of autoantibody epitopes of glutamic acid decarboxylase in stiff-man syndrome patients. J. Immunol. 152: 930-934.
12. ELLIS, T. M. & M. A. ATKINSON. 1996. The clinical significance of an autoimmune response against glutamic acid decarboxylase. Nature Med. 2: 148-153.
13. ROBERTS, A., B. LANG, A. VINCENT & J. NEWSOM-DAVIS. 1992. Search for cross-reactive idiotypes on monoclonal and myasthenia gravis acetylcholine receptor antibodies. Auto-immunity 12: 53-60.
14. GRAUS, Y. M. & B. M. H. DE. 1993. Myasthenia gravis: An autoimmune response against the acetylcholine receptor. Immunol. Res. 12: 78-100.
15. GRAUS, Y. M. & B. M. H. DE. 1994. Molecular and structural characterization of antiacetylcholine receptor antibodies in experimental autoimmune myasthenia gravis. Adv. Neuroimmunol. 4: 457-474.
16. CARDONA, A., O. PRITSCH, G. DUMAS, J. F. BACH & G. DIGHIERO. 1995. Evidence for an antigen-driven selection process in human autoantibodies against acetylcholine receptor. Mol. Immunol. 32: 1215-1223.
17. BUCKANOVICH, R. J., Y. Y. YANG & R. B. DARNELL. 1996. The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies. J. Neurosci. 16: 1114-1122.
18. MEMAR, O., B. CHRISTENSEN, S. RAJARAMAN, R. GOLDBLUM, S. K. TYRING, M. M. BRYSK, D. J. MCCORMICK, H. EL-ZAIM, J. L. FAN & B. S. PRABHAKAR. 1996. Induction of blister-causing antibodies by a recombinant full-length, but not the extracellular, domain of the pemphigus vulgaris antigen (desmoglein 3). J. Immunol. 157: 3171-3177.
19. ROGERS, S. W., P. I. ANDREWS, L. C. GAHRING et al. 1994. Autoantibodies to glutamate receptor 3 in Rasmussen's encephalitis. Science 265: 648-651.
20. TWYMAN, R. E., L. C. GAHRING, J. SPIESS & S. W. ROGERS. 1995. Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site. Neuron 14: 755-762.
21. SILLEVIS, S. P. A., G. T. MANLEY & J. B. POSNER. 1995. Immunization with the paraneoplastic encephalomyelitis antigen HuD does not cause neurologic disease in mice. Neurology 45: 1873-1878.
22. AHERN, G. L., M. O'CONNOR, I. DALMAU, A. COLEMAN, J. B. POSNER, D. L. SCHOMER, A. G. HERZOG, D. A. KOLB & M. M. MESULAM. 1994. Paraneoplastic temporal lobe epilepsy with testicular neoplasm and atypical amnesia. Neurology 44: 1270-1274.
23. HORMIGO, A., J. DALMAU, M. K. ROSENBLUM, M. E. RIVER & J. B. POSNER. 1994. Immunological and pathological study of anti-Ri-associated encephalopathy. Ann. Neurol. 36: 896-902.
24. SUNDKVIST, G., W. A. HAGOPIAN, M. LANDIN-OLSSON, A. LERNMARK, L. OHLSSON, C. ERICSSON & J. AHLMEN. 1994. Islet cell antibodies, but not glutamic acid decarboxylase antibodies, are decreased by plasmapheresis in patients with newly diagnosed insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 78: 1159-1164.
25. WARNER, S. J. C. & P. LIBBY. 1989. Human vascular smooth muscle cells. Target for and source of tumor necrosis factor. J. Immunol. 142: 100-109.
26. TAN, E. M. 1989. Antinuclear antibodies: Diagnostic markers for autoimmune disease and probes for cell biology. Adv. Immunol. 44: 93-151.
27. VON MUHLEN, C. A. & E. M. TAN. 1995. Autoantibodies in the diagnosis of systemic rheumatic diseases. [Review]. Semin. Arthritis Rheum. 24: 323-358.
28. HAY, E. M. & D. A. ISENBERG. 1993. Autoantibodies in central nervous system lupus. Br. J. Rheumatol. 32: 329-332.
29. WINFIELD, J. B., M. SHAW, L. M. SILVERMAN, R. A. EISENBERG, H. A. WILSON, III & D. KOFFLER. 1983. Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction. Am. J. Med. 74: 837-844.
30. HIROHATA, S., S. HIROSE & T. MIYAMOTO. 1985. Cerebrospinal fluid IgM, IgA, IgG indexes in systemic lupus erythematosus. Arch. Intern. Med. 145: 1843-1846.
31. HIROHATA, S. & T. MIYAMOTO. 1986. Increased intrathecal immunoglobulin synthesis of both kappa and lambda types in patients with systemic lupus erythematosus and central nervous system involvement. J. Rheumatol. 13: 715-721.
32. RUDH, I., T. OLSSON, F. LINDSTROM & T. SKOGH. 1985. Cerebrospinal fluid immunoglobulin abnormalities in systemic lupus erythematosus. J. Neurol. 48: 807-813.
33. MCLEAN, B. N., D. MILLER & E. J. THOMPSON. 1995. Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behcet's disease involving the nervous system. J. Neurol. Neurosurg. Psychiatry 58: 548-554.
34. KELLY, M. C. & J. A. DENBURG. 1987. Cerebrospinal fluid immunoglobulins and neuronal antibodies in neuropsychiatric systemic lupus erythematosus and related conditions. J. Rheumatol. 14: 740-744.
35. GOLOMBEK, S. J., F. GRAUS & K. B. ELKON. 1986. Autoantibodies in the cerebrospinal fluid of patients with systemic lupus erythematosus. Arthritis Rheum. 29: 1090-1097.
36. BOYER, R. S., N. C. J. SUN, A. VERITY, K. M. NIES & J. S. LOUIE. 1980. Immunoperoxidase staining of the choroid plexus in systemic lupus erythematosus. J. Rheumatol. 7: 645-650.
37. INOUE, T., M. OKAMURA, K. AMATSU, A. OLE, N. KATO & Y. KANAYAMA. 1982. Antineuronal antibodies in brain tissue of patient with systemic lupus erythematosus [letter]. Lancet 1: 852.
38. PERESS, N. S., V. A. ROXBURGH & M. C. GLENFAND. 1981. Binding sites for immune components in human choroid plexus. Arthritis Rheum. 24: 520-526.
39. MCINTOSH, R. W. & M. M. KOSS. 1974. The choroid plexus: Immunologic injury and disease. Ann. Intern. Med. 81: 111-113.
40. NILSSON, C., M. LINDVALL-AXELSSON & C. OWMAN. 1992. Neuroendocrine regulatory mechanisms in the choroid plexus- cerebrospinal fluid system. Brain Res. - Brain Res. Rev. 17: 109-138.
41. MOORE, P. M. 1992. Evidence for bound antineuronal antibodies in brains of NZB/w mice. J. Neuroimmunol. 38: 147-154.
42. WEST, S. G., W. EMLEN, M. K. WENER & B. L. KOTZIN. 1995. Neuropsychiatric lupus erythematosus: A 10-year prospective study on the value of diagnostic tests. Am. J. Med. 99: 153-163.
43. YOSHIO, T., J.-I. MASUYAMA, M. IKEDA, K. TAMAI, T. HACHIYA, T. EMORI, A. MIMORI, A. TAKEDA, S. MINOTA & S. KANO. 1995. Quantification of antiribosomal PO protein antibodies by ELISA with recombinant PO fusion protein and their association with central nervous system disease in systemic lupus erythematosus. J. Rheumatol. 22: 1681-1687.
44. HANLY, J. G., N. M. WALSH, J. D. FISK, B. EASTWOOD, C. HONG, G. SHERWOOD, J. V. JONES, E. JONES & K. ELKON. 1993. Cognitive impairment and autoantibodies in systemic lupus erythematosus. Brit. J. Rheumatol. 32: 291-296.
45. DERKSEN, R. H. W. M., A. P. VAN DAM, F. H. J. G. MEYLING, J. W. J. BULSMA & R. J. T. SMEENK. 1990. A prospective study on antiribosomal P proteins in two cases of familial lupus and recurrent psychosis. Ann. Rheum. Dis. 49: 779-782.
46. BONFA, E., S. J. GOLOMBEK, L. D. KAUFMAN, S. SKELLY, H. WEISSBACH, N. BROT & K. B. ELKON. 1987. Association between lupus psychosis and anti-ribosomal P protein antibodies. N. Engl. J. Med. 317: 265-271.
47. HOW, A., P. B. DENT, S.-K. LIAO & J. A. DENBURG. 1985. Antineuronal antibodies in neuropsychiatric system lupus erythematosus. Arthritis Rheum. 28: 789-795.
48. TEMESVARI, P., J. DENBURG, S. DENBURG, R. ARBOTTE, W. BENSEN & D. SINGAL. 1983. Serum lymphocytotoxic antibodies in neuropsychiatric lupus: A serial study. Clin. Immunol. Immunopathol. 28: 243-251.
49. KLEIN, R., C. RICHTER & P. A. BERG. 1991. Antibodies against central nervous system tissue (anti-CNS) detected by ELISA and Western blotting: Marker antibodies for neuropsychiatric manifestations in connective diseases. Autoimmunity 10: 133-144.
50. HANSON, V. G., M. HOROWITZ, D. ROSENBLUTH, H. SPIERA & S. PUSZKIN. 1992. Systemic lupus erythematosus patients with central nervous system involvement show autoantibodies to a 50-kD neuronal membrane protein. J. Exp. Med. 176: 565-573.
51. PAPERO, P. H., H. G. BLUESTEIN, P. WHITE & R. N. LIPNICK. 1990. Neuropsychologic deficits and antineuronal antibodies in pediatric systemic lupus erythematosus. Clin. Exp. Allergy 8: 417-424.
52. STILLER, J., A., GOODMAN, L. M. KAMHI, M. SACHER & M. B. BENDER. 1984. Neurosarcoidosis presenting as major depression. J. Neurol. Neurosurg. Psychiatry 47: 1050-1051.
53. HANLY, J. G., S. RAJARAMAN, S. BEHMANN & J. A. DENBURG. 1988. A novel neuronal antigen identified by sera from patients with systemic lupus erythematosus. Arthritis Rheum. 31: 1492-1499.
54. WYMAN, A. R. & K. F. WERTMAN. 1987. Host strains that alleviate underrepresenting of specific sequences: Overview. In Methods in Enzymology: Guide to Molecular Cloning Techniques: Volume 152: S. L. Berger & A. R. Kimmel, Eds.: 173-180. Academic Press, Inc. New York.
55. SIBBITT, W. L. J., C. KENNY, C. W. SPELLMAN, K. D. LEY & A. S. BANKHURST. 1984. Lymphokines in autoimmunity: Relationship between interleukin-2 and interferon-gamma production in systemic lupus erythematosus. Clin. Immunol. Immunopathol. 32: 166-173.
56. GRAUS, F., C. CORDON-CARDO, E. BONFA & K. B. ELKON. 1985. Immunochemical localization of La nuclear antigen in brain: selective concentration of the La protein in neuronal nuclei. J. Neuroimmunol. 9: 307-319.
57. NARENDRAN, A. & S. A. HOFFMAN. 1989. Autoantibody reactive integral membrane antigens of thymocytes and brain. J. Neuroimmunol. 24: 113-123.
58. MOORE, P. M. 1990. Immunoglobulin binding to neuronal cell surface epitopes in murine systemic lupus erythematosus. J. Neuroimmunol. 30: 101-109.
59. BLUESTEIN, H. G. & N. J. ZVAIFLER. 1983. Antibodies reactive with central nervous system antigens. Hum. Pathol. 14: 424-428.
60. BLUESTEIN, H. G., G. W. WILLIAMS & A. D. STEINBERG. 1981. Cerebrospinal fluid antibodies to neuronal cells: Association with neuropsychiatric manifestations of systemic lupus erythematosus. Am. J. Med. 70: 240-246.
61. BRESNIHAN, B., M. OLIVER, R. GRIGOR & G. R. V. HUGHES. 1977. Brain reactivity of lymphocytotoxic antibodies in systemic lupus erythematosus with and without cerebral involvement. Clin. Exp. Immunol. 30: 333-337.
62. DANON, Y. L. & B. Z. GARTY. 1986. Autoantibodies to neuroblastoma cell surface antigens in neuro-psychiatric lupus. Neuropediatrics 17: 23-27.
63. WILSON, H. A., J. B. WINFIELD, R. G. LAHITA & D. KOFFLER. 1979. Association of IgG anti-brain antibodies with central nervous system dysfunction in systemic lupus erythematosus. Arthritis Rheum. 22: 458-462.
64. QUISMORIO, F. P. & G. J. FRIOU. 1972. Antibodies reactive with neurons in SLE patients with neuropsychiatrie manifestations. Int. Arch. Allergy Apl. Immunol. 43: 740-748.
65. TOH, B. H. & I. R. MACKAY. 1981. Autoantibody to a novel neuronal antigen in systemic lupus erythematosus and in normal human sera. Clin. Exp. Immunol. 44: 555-559.
66. HUSBY, G., I. VAN DE RIJN, J. B. ZABRISKIE, Z. H. ABDIN & R. C. WILLIAMS. 1976. Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever. J. Exp. Med. 144: 1094-1110.
67. JOO, F. 1987. Mini Review. Current aspects of the development of the blood-brain barrier. Int. J. Dev. Neurosci. 5: 369-372.
68. DE VRIES, H. E., M. C. M. BLOM-ROOSEMALEN, M. VAN OOSTEN, A. DE BOER, T. J. C. VAN BERKEL, D. D. BREIMER & J. KUIPER. 1996. The influence of cytokines on the integrity of the blood-brain barrier in vitro. J. Neuroimmunol. 64: 37-43.
69. WISNIEWSKI, H. M. & A. S. LOSSINSKY. 1991. Structural and functional aspects of the interaction of inflammatory cells with the blood-brain barrier in experimental brain inflammation. Brain Pathol. 1: 89-96.
70. STITT, J. T. 1990. Passage of immunomodulators across the blood-brain barrier. Yale J. Biol. Med. 63: 121-131.
71. HICKEY, W. F. 1991. Migration of hematogenous cells through the blood-brain barrier and the initiation of CNS inflammation. Brain Pathol. 1: 97-105.
72. HICKEY, W. F., B. L. HSU & H. KIMURA. 1991. T-Lymphocyte entry into the central nervous system. J. Neurosci. Res. 28: 254-260.
73. SABHARWAL, U. K., L. H. KEOGH, M. H. WEISMAN & N. J. ZVAIFLER. 1982. Granulomatous angiitis of the nervous system: Case report and review of the literature. Arthritis Rheum. 25: 342-345.
74. DRAKE, J. R., E. A. REPASKY & R. B. BANKERT. 1989. Endocytosis of antigen, antiidiotype, and anti-immunoglobulin antibodies and receptor re-expression by murine B cells. J. Immunol. 143: 1768-1776.
75. GRAUS, F., C. CORDON-CARDO & J. B. POSNER. 1985. Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology 35: 538-543.
76. FURNEAUX, H. F., L. REICH & J. B. POSNER. 1990. Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes. Neurology 40: 1085-1091.
77. VINCENT, A., B. LANG & J. NEWSOM-DAVIS. 1989. Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder. Trends Neurosci. 12: 496-502.
78. KORNGUTH, S. E. 1989. Neuronal proteins and paraneoplastic syndromes. N. Engl. J. Med. 321: 1607-1608.
79. GAHRING, L. C., R. E. TWYNAN, J. GREENLEE & S. W. ROGERS. 1995. Autoantibodies to neuronal glutamate receptors in patients with paraneoplastic neurodegenerative syndrome enhance receptor activation. Mol. Med. 3: 245-253.
80. RODRIGUEZ, M. & V. A. LENNON. 1990. Immunoglobulins promote remyelination in the central nervous system. Ann. Neurol. 27: 12-17.
81. DICOU, E., D. HUREZ & V. NERRIERE. 1993. Natural autoantibodies against the nerve growth factor in autoimmune diseases. J. Neuroimmunol. 47: 159-168.
82. BURRES, S. A., J. W. CRAYTON, C. M. GOMEZ & D. P. RICHMAN. 1981. Myasthenia induced by monoclonal anti-acetylcholine receptor antibodies: Clinical and electrophysiological aspects. Ann. Neurol. 9: 563-568.
83. DRACHMAN, D. B., R. N. ADAMS, L. F. JOSIFEK & S. G. SELF. 1982. Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. N. Engl. J. Med. 307: 769-775.
84. NAKANO, S. & A. G. ENGEL. 1993. Myasthenia gravis: Quantitative immunocytochemical analysis of inflammatory cells and detection of complement membrane attack complex at the end-plate in 30 patients. Neurology 43: 1167-1172.
85. DENENBERG V. H., G. F. SHERMAN, L. M. SCHROTT, G. D. ROSEN & A. M. GALABURDA. 1991. Spatial learning, discrimination learning, paw preference and neocortical ectopias in two autoimmune strains of mice. Brain Res. 562: 98-104.
86. SHERMAN G. F., L. MORRISON, G. D. ROSEN, P. O. BEHAN & A. M. GALABURDA. 1990. Brain abnormalities in immune defective mice. Brain Res. 532: 25-33.
87. KIER A. B. 1995. Clinical neurology and brain histopathology in NZB/NZW F1 lupus mice. J. Comp. Pathol. 102: 165-177.
88. VOGELWEID, C. M., D. C. WRIGHT, J. C. JOHNSON, J. E. HEWETT & S. E. WALKER. 1994. Evaluation of memory, learning ability, and clinical neurologic function in pathogen-free mice with systemic lupus erythematosus. Arthritis Rheum. 37: 889-897.
89. DENENBERG, V. H., G. F. SHERMAN, L. MORRISON, L. M. SCHROTT, N. S. WATERS, G. D. ROSEN, P. O. BEHAN & A. M. GALABURDA. 1992. Behavior, ectopias and immunity in BD/DB reciprocal crosses. Brain Res. 571: 323-329.
90. SHROTT, L. M., V. H. DENENBERG, G. F. SHERMAN, N. S. WATERS, G. D. ROSEN & A. M. GALABURDA. 1992. Environmental enrichment, neocortical ectopias, and behavior in the autoimmune NZB mouse. Dev. Brain Res. 67: 85-93.
91. SHERMAN, G. P., A. M. GALABURDA, P. O. BEHAN & G. D. ROSEN. 1987. Neuroanatomical anomalies in autoimmune mice. Acta Neuropathol. 74: 239-242.
92. MOORE, P. M., I. JOSHI & S. M. GHANEKAR. 1994. Affinity isolation of neuron reactive antibodies in MRL/lpr Mice. J. Neurosci. Res. 39: 140-147.